Walleye Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$31.4K 4870
2025
Q2
$31.4K Buy
+100
New +$30K ﹤0.01% 4156
2024
Q3
Sell
-4,700
Closed -$1.94M 5648
2024
Q2
$1.94M Buy
4,700
+1,300
+38% +$515K ﹤0.01% 2142
2024
Q1
$1.37M Buy
3,400
+1,700
+100% +$598K ﹤0.01% 2283
2023
Q4
$521K Sell
1,700
-5,000
-75% -$1.35M ﹤0.01% 2914
2023
Q3
$1.62M Buy
+6,700
New +$1.71M ﹤0.01% 1891
2023
Q1
Sell
-400
Closed -$85K 4202
2022
Q4
$85K Buy
+400
New +$79.9K ﹤0.01% 2407

Other funds holding MEDP

Walleye Capital's MEDP Position: Q1 2026 in Review

Walleye Capital reduced its Medpace (MEDP) stake by 35% in Q1 2026, selling an estimated $1.62M and leaving 5,995 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #1180.

Walleye Capital first reported a position in MEDP in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.14M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Walleye Capital held 5,995 shares of Medpace worth $2.88M as of Q1 2026.
  • Walleye Capital sold 3,162 Medpace shares in Q1 2026, an estimated $1.62M.
  • Medpace made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1180 holding.
  • Walleye Capital first reported a position in Medpace in Q3 2021 and has held it in 8 quarters since.
  • Walleye Capital's Medpace position peaked at $5.14M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.